Name | Type | Posted | Actions |
|---|---|---|---|
Amend_1_75F40125R00037_QR.pdf | Jun 25, 2025 | ||
Amend_1_75F40125R00037_Attachment 7 - FDA Secure Electronic Mail System.pdf | Jun 25, 2025 | ||
Amend_1_75F40125R00037_Attachment 14 - Task Order Statement of Work.pdf | Jun 25, 2025 | ||
Amend_1_75F40125R00037_Attachment 13 - Pricing Worksheet.xlsx | XLSX | Jun 25, 2025 | |
Amend_1_75F40125R00037.pdf | Jun 25, 2025 | ||
Sol_Doc_75F40125R00037_Attachment 5 - Census Regions.pdf | Jun 2, 2025 | ||
Sol_Doc_75F40125R00037_Attachment 8 - Active FAR - HHSAR Class Deviations.pdf | Jun 2, 2025 | ||
Sol_Doc_75F40125R00037_Attachment 12 - Past Performance Questionnaire.docx | DOCX | Jun 2, 2025 | |
Sol_Doc_75F40125R00037_Attachment 11 - Past Performance Worksheet.docx | DOCX | Jun 2, 2025 | |
Sol_Doc_75F40125R00037_Attachment 10 - Example of Monthly Report.xlsx | XLSX | Jun 2, 2025 | |
Sol_Doc_75F40125R00037_Attachment 9 - HHS Subcontracting Plan.pdf | Jun 2, 2025 | ||
Sol_Doc_75F40125R00037_Attachment 4 - Data Disclosure Clearance Forms.docx | DOCX | Jun 2, 2025 | |
Sol_Doc_75F40125R00037_Attachment 3 - Data Disclosure Clearance Procedures.docx | DOCX | Jun 2, 2025 | |
Sol_Doc_75F40125R00037_Attachment 1 - Data Characteristics Table.pdf | Jun 2, 2025 | ||
Sol_Doc_75F40125R00037.pdf | Jun 2, 2025 | ||
Sol_Doc_75F40125R00037_Attachment 2 - Glossary.pdf | Jun 2, 2025 | ||
Sol_Doc_75F40125R00037_Attachment 13 - Pricing Worksheet.xlsx | XLSX | Jun 2, 2025 | |
Sol_Doc_75F40125R00037_Attachment 7 - FDA Secure Electronic Mail System.pdf | Jun 2, 2025 | ||
Sol_Doc_75F40125R00037_Attachment 14 - Task Order Statement of Work.pdf | Jun 2, 2025 | ||
Sol_Doc_75F40125R00037_Attachment 6 - Trial Subscription Agreement.docx | DOCX | Jun 2, 2025 |
Access to Outpatient Longitudinal Data IDIQ
Contact and place of performance
Noah Wills
Silver Spring, MD
USA
This is a combined synopsis/solicitation for commercial products or commercial services prepared in accordance with the format in subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. The solicitation is issued as a request for proposal (RFP) in accordance with...
View moreThe Food and Drug Administration (FDA) Office of Acquisition and Grant Services is soliciting proposals for the Access to Outpatient Longitudinal Data Indefinite-Delivery Indefinite-Quantity (IDIQ) contract. This requirement is classified under NAICS code 541519, Other Computer Related Services, and PSC code B529, Special Studies/Analysis- Scientific Data. The agency intends to award a multiple-award IDIQ to approximately two offerors representing the best value to the government based on technical, price, and other factors. While the solicitation is unrestricted, the FDA intends to reserve at least one additional award for a small business concern.
The scope of this combined synopsis/solicitation involves providing access to longitudinal data for outpatient settings to support scientific analysis. The government is concurrently soliciting both the overarching IDIQ and Task Order #1, and offerors must submit separate proposals for both to remain eligible for award. Performance will take place in Silver Spring, Maryland, and the solicitation is managed under solicitation number 75F40125R00037.
Interested parties must submit their proposals by the response deadline of July 3, 2025. The solicitation includes 20 attachments, such as the Task Order Statement of Work, the Pricing Worksheet, and recent amendments addressing solicitation questions. Vendors are required to maintain an active registration in SAM.gov and utilize the specific pricing worksheet provided in Amendment 1 to account for updated performance periods and contract values. All correspondence for this acquisition is directed to the point of contact, Noah Wills.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.